aTyr Pharma Inc. (ATYR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    aTyr Pharma Inc.

    NASDAQ: ATYR · Real-Time Price · USD
    5.61
    0.14 (2.56%)
    At close: Sep 05, 2025, 3:59 PM
    5.58
    -0.53%
    After-hours: Sep 05, 2025, 07:55 PM EDT

    aTyr Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 235K 353K 10.39M n/a
    Cost of Revenue
    		 n/a 2.74M 1.7M 1.3M
    Gross Profit
    		 235K 353K 8.69M -1.3M
    Operating Income
    		 -67.91M -54.92M -46.4M -34.02M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -64.02M -50.4M -45.34M -33.78M
    Net Income
    		 -64.02M -50.39M -45.34M -33.77M
    Selling & General & Admin
    		 13.78M 12.98M 12.29M 10.75M
    Research & Development
    		 54.37M 42.29M 42.81M 23.26M
    Other Expenses
    		 n/a n/a n/a -1.3M
    Operating Expenses
    		 68.15M 55.27M 55.09M 32.71M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a -1.7M -1.3M
    Cost & Expenses
    		 68.15M 55.27M 56.79M 34.02M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 74.26M 53.61M 28.42M 19.08M
    Shares Outstanding (Diluted)
    		 74.26M 53.61M 28.42M 19.08M
    EPS (Basic)
    		 -0.86 -0.94 -1.6 -1.77
    EPS (Diluted)
    		 -0.86 -0.94 -1.6 -1.77
    EBITDA
    		 -66.37M -52.18M -44.71M -32.47M
    EBIT
    		 -67.91M -54.92M -46.4M -33.78M
    Depreciation & Amortization
    		 1.54M 2.74M 1.7M 1.3M

    Add to Watchlist